B+
Bull case
25%
Probability
Target price
$18.00
Analysis reference price unavailable
Analysis 2026-05-08 · RankAlpha Sentiment Codex
KRRO
Korro BioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The post-earnings company update kept the central upside case intact: KRRO-121 is still guided to a second-half 2026 regulatory filing, the AATD program remains on track for a second-quarter 2026 development-candidate nomination, a third GalNAc-conjugated program nomination is targeted for the second half of 2026, and management says the balance sheet can fund operations into the second half of 2028 [#8-K-2026-05-07][#10-Q-2026-05-07].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -7.2.
What can break
Even with runway improved into the second half of 2028, management says additional capital may still be required over time to fund development, manufacturing, and commercialization efforts [#10-Q-2026-05-07].
Momentum
61
Value
41
Sentiment
63
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $14.00 · Bull $18.00 · Bear $8.00Analysis 2026-05-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $20.00
Why
Momentum61 · Δ7d -32.5
Value41 · Δ7d -0.0
Sentiment63 · Δ7d -7.2
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -7.2.
Contradictions & invalidation
- • Even with runway improved into the second half of 2028, management says additional capital may still be required over time to fund development, manufacturing, and commercialization efforts [#10-Q-2026-05-07].
- • Korro remains pre-revenue and reported a Q1 2026 net loss of $19.6 million, with management still expecting operating losses and negative cash flow to continue [#10-Q-2026-05-07].
- • The earnings release did not provide a clear external beat-versus-consensus signal, and trusted post-print analyst target or estimate revisions were not available in the checked evidence.
Catalyst clock
2026-05-31
Q1 earnings reset extends runway but looks partly absorbed
Lead driver: Sentiment · See AI snapshot
Momentum
61
9% active weight
Current posture
7d trendSoftening
Δ7d
-32.5
Δ21d
+10.2
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
63
62% active weight
Current posture
7d trendSoftening
Δ7d
-7.2
Δ21d
+8.6
Why this grade
Composite grade C. Momentum 60.7 / Value 41.2 / Sentiment 63.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-05-08. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$14.00
Analysis reference price unavailable
Analysis 2026-05-08 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$8.00
Analysis reference price unavailable
Analysis 2026-05-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$193.5M
Beta
2.98
Shares Out
14.73M
P/E (TTM) · Derived
-1.1
P/S (TTM)
10.22
P/FCF (TTM) · Derived
-2.16
Rev YoY
-100.0%
EPS YoY
-60.9%
Gross Margin
-10.4%
Op Margin
-1366.4%
Net Debt
-$32.67M
Current Ratio
9.55
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data